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ABSTRAK 
Latarbelakang. Garis panduan trauma massif untuk kes  trauma major adalah 
berdasarkan kombinasi keputusan makmal dan penilaian klinikal. Beberapa keputusan 
makmal yang diperlukan tidak diperoleh dengan segera. Keputusan tepat dan cepat oleh 
doktor pada keadaan pesakit semasaa adalah penting.  Transfusi massif melibatkan jumlah 
beg darah yang banyak maka memerlukan komunikasi yang berkesana diantara doktor yang 
merawat dengan tabung darah. Identifikasi awal kemungkinan transfuse massif pada kes trauma 
akut membantu resusitasi kecemasan yang berkesan terhadap pesakit.    
 
Objektif. Menentukan prevalens trauma major di kalangan pesakit dewasa yang terlibat 
dengan trauma major serta menentukan faktor yang berhubungan dengan transfusi yang 
banyak bagi kes major trauma .   
 
Kaedah.  Kajian retrospektif di kalangan pesakit dewasa yang terlibat trauma major 
tanpa sebarang penyakit sedia ada yang dimasukkan ke Jabatan Kecemasan dan 
Kemalangan Hospital Kuala Lumpur anatra Jun 2015 sehingga Mei 2016. Tujuh faktor 
berhubungan transfusi darah masif telah ditetapkan iaitu detak jantung ≥120kali/minit, 
tekanan darah sistolik <90 mmHg, skala koma Glasgow ≤8, patah tulang pinggul yang 
tidak stabil, positif cairan pada pemeriksaan sonografi segera berfokuskan trauma, 
pengurangan pengalkalian darah  >6 mmol/L, hemoglobin ≤11 g/dL dan luka tembus.   
 
Results. 134 pesakit telah disertakan dalam kajian, 3 kes telah ditransfusi masif 
(2.27%). Factor yang menunjukkan hubungan bermakna dengan transfusi masif pada 
kes trauma major adalah nilai hemoglobin <11g/dl (p-value 0.029, 95% CI 1.423, 
739.568). Lain-lain faktor berhubungan tidak mempunyai kebermaknaan secara statistik 
kerana terhadnya jumlah sampel.  
 
Kesimpulan. Prevalens transfuse masif pada kes trauma major dalam kajian ini adalah 
rendah (2.2%). Walaupun begitu, hanya nilai hemoglobin <11 g/dL yang bermakna 
sebagai indikator perlunya tranfusi massif dalam kajian ini.  
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ABSTRACT 
 
Background. Our current guideline in managing major trauma in need of massive 
transfusion was based on both laboratory and clinical judgement. Some laboratory 
investigation is not immediate available that is not in keeping with rapid dynamic of 
trauma coagulopathy. Clinician prompt action on patient`s clinical presentation is 
essential. Massive transfusion need a lot of blood products thus it required effective 
communication between clinician and blood bank. Early recognition of massive 
transfusion likelihood in major trauma aid in prompt damage control resuscitation in 
major trauma patient. 
 
Objective.  To determine the prevalence of major trauma patient among adult and to 
determine the associated factors with massive transfusion in subjects enrolled. 
 
Methods.  Retrospective study on adult major trauma patients without unfavorable 
premorbid condition presented to Emergency Department of  Hospital Kuala Lumpur 
between June 2015 until May 2016. Associated factors are predefined with seven 
variables that are heart rate ≥120/min, systolic blood pressure <90 mmHg, Glasgow 
coma scale ≤8, displaced pelvic fracture, FAST scan positive for fluid, base deficit >6 
mmol/L, hemoglobin ≤11 g/dL and penetrating injury. 
 
Results. There were 134 patients been recruited, with 3 subjects in massive transfusion 
group. (2.27%). Multivariate analysis showed only factor of haemoglobin ≤11 g/dL  
(OR 32.443, p-value 0.029, 95% CI 1.423, 739.568)  found to be significantly 
associated with adult major trauma patients. Other factors do not statistically statistic 
due to small sample size. 
 
Conclusions. Prevalence of massive transfusion in adult major trauma patients in 
EDHKL was low (2.2%), however only haemoglobin <11 g/dL found to be significantly 
associated with massive transfusion in this study.  
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     CHAPTER 1 
INTRODUCTION 
 
1.1 Title 
Prevalence and associated factors of massive transfusion in major trauma among previously 
healthy adult patients at Emergency Department Hospital Kuala Lumpur 
 
1.2 Overview 
 
Massive transfusion was early recognized and developed in military practice since 
World War I.  The fact that abundant trauma cases with high likelihood of transfusion in 
military field due to haemorrhage, the understanding of haemorrhagic  pathophysiology is 
evolving as well as the massive transfusion practice both in military and civilian practice. 
In massive and uncontrolled bleeding as in commonly seen in major trauma cases, 
transfusion is an empiric mode of treatment to restore the oxygenation, maintaining the 
circulatory volume and prevention of ongoing bleeding by overcome the coagulopathy 
(Segatchian & Samama, 2012)   
 
Massive transfusion has been defined based on volume of blood loss or volume of 
blood transfused (Australia National Blood Authority). Definition of transfusion of  > 10 
units of red blood cells (RBCs) is mostly used in many research (Rainer et al., 2011., Elmer 
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et al., 2013;  Callcutt et al., 2013). This is correspond with other definition, in which 
transfusion is considered massive when there is transfusion of a volume equal to the 
patients` total blood volume in less than 24 hours (National Blood Centre Ministry of 
Health Malaysia, 2008a; Makroo et al., 2011). Other definitions includes loss of half of 
blood volume within 3 hours or use of 50 units of blood components in 24 hours and use of 
6 units RBCs in 12 hours (Smith et al., 2014). In real-time clinical situation, massive 
transfusion is highly anticipated in bleeding cases that required more than 4 unit of packed 
red cells within 1 hour with clinically still in need of transfusion, or blood loss more than 
150ml/minute with unstable haemodynamic status (Smith et al., 2014).  
 
Trauma is a major cause of mortality worldwide which reported as 4 million deaths 
a year (Curry et al., 2012). It is the leading cause of death worldwide in below 45 years age 
group (Curry et al., 2012; Rainer et al., 2011). Forty percent deaths were mainly caused by 
massive haemorrhage due to exsanguinations and occurred in the initial few hours of the 
event (Sauia  et al., 1995).  Associated risks of mortality in trauma are early coagulopathy, 
acidosis and hypothermia (Rainer et al., 2011). These lethal events are also known as the 
lethal triad. Traditionally, clinicians thought that coagulopathy in trauma patients was due 
to the dilution effect of massive transfusions of crystalloid and packed red cells (Livingston 
et al., 2014). There is now a growing appreciation that the causes of coagulopathy is 
multifactorial and may be induced by the inflammatory response to traumatic injuries, 
independent of fluid resuscitation and transfusion (Livingston et al., 2014). Thus, the 
development of massive transfusion protocol is expected to guide resuscitation, facilitate 
communication and logistical support, and prevent coagulopathy before it occurs 
(Livingston et al., 2014).  
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Malaysia`s National Trauma Registry in 2009 reported that  major trauma accounted 
to 1.2% from total of 166,768 admissions in emergency and trauma centre nationwide with 
27.9% mortality. The highest risk group of age is 15 – 34 years old which accounted to 
56.6% of incidence (National Trauma Database, Ministry of Health Malaysia, 2009). 
 
The polemic is arise between the aim of lifesaving and dose-related adverse effects 
in massive transfusion (Seghatchian and Samama, 2012). Massive transfusion carries a 
significantly mortality rate of 40% which increases with the number of volume expanders 
and blood components used (Seghatchian and Samama, 2012). The large amount of blood 
products used lead to the dilution effect resulting the vicious cycle of coagulopathy, 
hypothermia and acidosis that may complicate the haemorrhagic trauma event (Kashuk et 
al., 1982; Gustavo et al., 2010). Nonetheless, massive transfusion may exposed the 
recipient to biological response modifiers that may cause unwanted harmful effects 
(Seghatchian and Samama, 2012). 
 
Most previous studies that are mainly a long-term retrospective studies, showed that 
there were significant adverse outcome among patients who had been massively transfused. 
One of these studies, by Livingston (2014) found that adolescent and paediatric patients 
who received massive transfusion had poor clinical outcomes, including increased length of 
hospital stay and higher in-hospital mortality (Livingston et al., 2014). Mitra (2012) 
reported that massively transfused elderly patient had significant mortality (21.1% in 
elderly, p < 0.01) compare to younger patients (Mitra et al., 2012).  Rainer et al. also 
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reported that mortality were significantly higher by 54.3% in trauma patient with massive 
transfusion and had longer hospital length of stay (Rainer et al., 2011).  
Massive transfusion protocol was postulated to significantly improve the outcome in 
major haemorrhage patients by early communication between both physician and blood 
bank personnel (Malone et al., 2006; Callcut, et al., 2013). Strategies for controlling 
haemorrhage in the protocol is aimed for good oxygenation restoration, volume 
replacement as well as early prevention of coagulopathy (Malone et al., 2006; Segatchian 
and Samama, 2012; Smith et al., 2014). Besides, time to initiate the balanced resuscitation 
is postulated to be a major determinant for the improved outcomes (Callcut et al., 2013). 
Therefore early recognition of cases that need an activation of massive transfusion protocol 
(MTP) is important. There are various of predictive factors scoring for massive transfusion 
in emergency and trauma settings. Several factors that are included type of high risk injury, 
haemodynamic (blood pressure and heart rate), haemoglobin level, and base deficit. Each 
scoring factor differ in variable factors included and point scoring (Brockamp et al., 2012).  
 An example of massive transfusion predictive factors scoring in Asia region done 
by Rainer (2011) at Prince Wales Hospital in Hong Kong, also known as PWH score 
(Rainer et al., 2011; Brockamp et al, 2012). They found seven variables for predicting 
massive transfusion needs in major trauma which are heart rate ≥120/minutes (HR), 
systolic blood pressure (SBP), Glasgow Coma Scale ≤8 (GCS), displaced pelvic fracture, 
computed topography scan (CT scan) or Focused Assessment Sonography in  Trauma  
(FAST) positive for fluid, base deficit >5 mmol/L, and haemoglobin ≤7 g/dL; and 
haemoglobin 7.1-10 g/dL (Rainer et al, 2011).   
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LITERATURE REVIEW 
 
1.3.1 Pathophysiology of Major Trauma 
 
Massive bleeding and tissue injury are the main causes for adverse clinical 
consequences in major trauma.  Sauia (1995)  wrote that forty percent death in major 
trauma were caused by massive bleeding and higher risk to have early mortality in first few 
hours (Sauia et al., 1995). Nevertheless, this major cause of death in trauma is potentially 
preventable (Spahn et al., 2013). Haemorrhagic shock due to massive bleeding in trauma is 
initiated by hypovolemia and tissue hypoperfusion which latter causes inflammatory 
response and acidosis (Smith et al., 2014). Trauma  causes tissue injury that trigger the 
haemostasis system activation comprising of vascular endothelium, platelet activation, 
coagulation and fibrinolysis, in which if severe enough may lead to disseminated 
intravascular coagulopathy and hyperfibrinolysis (Elmer et al., 2012). Presence of both 
tissue injury and massive haemorrhage in major trauma with systemic hypoperfusion lead 
to the endogenous coagulopathy is associated with higher risk of multiorgan failure and 
poor outcomes (Frith et al., 2012; Spahn et al., 2013). 
 
1.3.1 Acute Trauma Coagulopathy  
Multifactorial primary condition has been recognised as a trigger for acute traumatic 
coagulopathy. Those factors  are combinations of  bleeding-induced shock, tissue injury 
related thrombin-thrombomodulin-complex generation and the activation of anticoagulant 
and fibrinolytic pathways (Frith et al., 2012). Hypoperfusion increases the expression of 
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thrombomodulin on endothelium in which later  forms a complex with thrombin, thus  
reduces the amount of thrombin. As a result, fibrin production is decreased and there will 
be an increment in circulating activated protein C (Smith et al., 2014). Haemodilution is 
resulted from initial fluid resuscitation for replacing volume in bleeding trauma patient and 
this can lead to dilutional coagulopathy (Bolliger et al., 2010). Both acidosis and 
haemodilution causes altered enzyme activity, reduced thrombin activity thus aggravate the 
coagulopathy   (Schöchl et al., 2012).  
 
Lethal viscious cycle in trauma occured as coagulopathy progresses, which 
worsened the harmorrhage and the existing systemic shock. This unfavorable state 
presented as as refractory coagulopathy, progressive hypothermia and persistent metabolic 
acidosis (Smith, et al., 2014). 
 
It is reported that one out of four trauma patients had coagulopathy on admission 
with significant higher risk of bleeding and  mortality (MacLeod et al., 2014). MacLeod 
(2014) defined the ATC in their study as prolongation of PT > 13.3 seconds. The 
prolongation of PTT was low in trauma (2.5%) thus in their study, only PT measurements 
been considered in the definition of ATC (Mac Leod, 2014). Current trauma management 
guideline is recommended on immediate treatment of haemostatic resuscitation to ensure 
prompt recognition of patient with risk of traumatic coagulopathy and minimise the blood 
loss (Curry et al., 2012; Spahn et al., 2013). Haemostatic resuscitation is early 
administration of procoagulant products such as fresh frozen plasma, cryoprecipitate, 
platelet and other coagulation factor concentrates along with transfusion of red cells and 
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limiting fluid infusion (Frith et al., 2012). Apart from controlling the coagulopathy, the 
damage control resuscitation in trauma is essential by controlling the bleeding source as 
soon as possible, correction and prevention of hypothermia, restoring tissue perfusion and 
subsequently attain stable haemodynamic status (Smith et al., 2014).  
 
1.4  Massive Transfusion in Major Trauma 
 
Massive transfusion (MT) is widely defined in many studies as the use of > 10 
units of packed red cells within 24 hour (Elmer et al., 2013). It is also be defined as massive 
transfusion of > 50 blood components in 24 hour (Smith et al., 2014). Holcomb (2010) 
wrote in his article that traditionally, the use blood and blood products with fluid 
resuscitation is always not in proper algorithm and resulting in large volume of fluid 
infusion, red cells transfusion then only plasma, cryoprecipiate and platelet be considered 
in small volume (Holcomb J.B., 2010). This practice is been revised since the knowledge of 
acute traumatic coagulopathy (ATC) start to be established and dilutional effect of over-
resuscitation take into account (Holcomb J.B., 2010).  
Current practice of massive transfusion has evolved by US military experience in 
Iraq, whereby balance resuscitation has been introduced (Fraga et al., 2010). The aim is, to 
achieve well balance of haemodynamic and haemostatic resuscitation in bleeding major 
trauma management (Kua et al., 2014). Balanced resuscitation is aggressive resuscitation 
with minimal fluids, early use of red cells transfusion, fresh frozen plasma, platelet and 
cryoprecipitate (Holcomb J. B., 2010). This strategy is to encounter ATC by haemostatic 
resuscitation and avoiding dilutional effects. Balanced resuscitation can avoid dilutional 
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coagulopathy that may worsened the haemorrhage especially in massive transfusion 
(Seghatchia and Samama, 2012). The earliest suggestion red cells, fresh frozen plasma and 
platelet ratio was 1:1:1 that been had adopted from Iraq war experience (Fraga et al., 2010).  
 
1.4.1  Massive transfusion protocol 
Since acute trauma coagulopathy occured in early period of injury with significant 
poor outcomes, prompt action is needed to overcome this. The approach need timely risk 
assessment and standardised protocols (Maegele et al., 2003). Massive transfusion protocol 
(MTP) can reduce risk of mortality and morbidity in trauma cases (Morris A. H., 2003). 
The other aim of MTP is to ensure effective sources utilization that promotes judicious use 
of blood in safe timely supply of blood products, as well as the need to incorporate proper 
and valid laboratory testing for monitoring of laboratory value that related to therapy 
effectiveness (Shaz et al., 2009). Hence, MTP need effective cooperation and 
communication between laboratory personnel, clinician and blood bank personel, and it is 
effectively done in agreed local evidence-based algorithm (Elmer et al, 2012; Rossaint et 
al., 2016).   
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1.4.2   Blood and blood products usage in balanced massive transfusion 
 
The understanding of trauma coagulopathy changes the paradigm to the using of 
higher ratio of  plasma to red cells in trauma massive transfusion. Borgman (2007) analysed 
restrospectively the association of ratio of plasma to red cells and survival rate in massively 
transfused patients in military hospital (Borgman et al., 2007).  They found that patients 
who were receiving low ratio of plasma to red cells (1:8) had highest mortality rate (65%) 
and highest percentage of hemorraghic death (92.5%), as compared in high ratio group 
(1:1.4) with mortality rate of 19% and hemorrhagic death 37% (Borgman et al., 2007). This 
finding brought the suggestion to utilize formula based trauma massive  transfusion with 
ratio plasma to red cells of 1:1 especially in those with high risk of hypocoaguable state 
(Borgman et al., 2007). In other study Bhangu (2013) in which they did a meta-analysis 
study on plasma to red cells ratio from published literature of trauma massive transfusion 
(Bhangu et al., 2013). They found that ratio of plasma to red cells of  >1:2 has significant 
reduction in mortality, while there was no additional benefit identified in  1:1 over 1:2 
transfusion ratios (Bhangu et al., 2013).  There was another thought that the association of 
high plasma to red cells ratio and survival rate is biased (Snyder et al., 2009). In their study 
by  Snyder (2009) they found that  higher ratio of plasma to red cells (>1:2 vs <1:2), had 
63% lower mortality risk (Snyder et al., 2009). They also analyse the timing of product 
administration and found that survived patients received plasma later than the red cells (>60 
minutes). Thus, they speculating that the survival rate is biased by highlighting the 
administration of plasma without clear data regarding how early it had been transfused 
(Snyder et al., 2009). There is recent study by Holcomb (2015) in which they done a 
prospective pragmatic randomized controlled trial of effectiveness of plasma, platelet and 
 10 
 
red cells ratio at 1:1:1 and 1:1:2 (Holcomb et al., 2015).  They found that there is no 
significant differences in 24 hour or 30 days mortality between these two ratio. In this 
study, patient received blinded package of bloods according to ratio and be availabe within 
10 minutes, the transfusion order is platelet than alternate plasma and red cells. This study 
also showed 1:1:1 ratio group had better haemostasis outcome and less mortality within 24 
hour and no additional adverse effects even more products been used.  This study findings 
support the practice of fix ratio 1:1 of plasma to red cells. It is suggested further study of 
the impact on judicious use of blood and outcome in separate times, early (within 24 hour) 
and 30 days (Holcomb et al., 2015).  
 
 The plasma use for fix ratio transfusion in preferrable thawed AB plasma that 
shortened plasma supply time (Callum et al., 2009). AB plasma does not contain anti-A and 
anti-B thus preferrable to be transfuse in emergency situation in which in recipients`s blood 
group yet to be identified (Shaz et al., 2013). Usually, longer time is needed for plasma to 
be ready compare to red cells, approximately 35-45 mins due to thawing process and 
logistic issue (Sorensen and Fries., 2012).  
 
The formula driven approach in transfusion management of major trauma has 
advantage over laboratory base practice as it it did not require long turn around time (TAT), 
as conventional laboratory based is guided by PT/APTT which have TAT ranges between 
29-235 minutes (Toulon et al., 2009). Arguments on it`s practice are the possibility 
exposure of harmful biological substance especially in plasma and platelet to patients with 
unknown risks, increase risk of adverse events of transfusion such as TRALI, risk of FFP 
wastage and may compromised the availibility for other clinically indicated in need of 
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plasma ie: exchange transfusion in thrombocytopenic purpura (Callum et al., 2009). The 
use of fixed protocol is mainly during acute haemorrhage, once haemorrhage is controlled, 
transfusion should be guided laboratory findings (Holcomb et al., 2015). 
 
1.4.3  Goal directed haemostatic resuscitation in major trauma blood transfusion 
 
Alternative approach to transfusion in trauma cases is based on goal-directed 
coagulation using thromboelastography (TEG)  or rotational thromboelastometry 
(ROTEM) (Bougle et al., 2013). These techniques give rapid result and represent the 
coagulation abnormality reflecting either plasmatic coagulation system, platelet function or 
fibrinolysis (Brazzel, C., 2013). The result can be obtained within as early as 5-10 minutes, 
but could be longer in detecting hyperfibrinolysis (30-60mins) (Wang W. et al.,  2016; 
Schochl et al., 2012). Thus it can guide the transfusion need either for FFP, platelet or 
cryoprecipitate (fibrinogen source) which make possible of judicious use of blood products, 
reduce wastage of products and limiting the adverse effects of transfusion (Malone et al., 
2013). 
 
Despite the goal-directed coagulation profile and rapid results of TEG, it`s efficacy 
and accuracy has not been proven to be more superior than conventional coagulation test 
(Da Luz et al, 2014). A Cochrane systematic review by Hunt (2015) shows no evidence of 
TEG accuracy and small evidence for ROTEM accuracy as diagnostic tool of trauma 
induced coagulopathy, but their findings were limited to small number of studies (Hunt et 
al., 2015). Da Luz (2014)  in their descriptive observational study showed that there was 
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limited evidence of TEG/ROTEM superiority in improving blood transfusion strategy and 
the overall outcome in patients`s survival (Da Luz et al., 2014). Study on trauma patient`s 
outcome in TEG guided and standard massive transfusion protocol by Tapia et al. showed 
that TEG-guided resuscitation is effectively equivalent to standard massive transfusion 
protocol (with fix 1:1:1 ratio of red cells, plasma and platelet) in blunt injury but there was 
no significant different in outcome (Tapia et al., 2013). They also suggested that standard 
blood products ratio was not suitable for all trauma patients since there was worse outcome 
found in penetrating trauma with standard MTP group, thus the recommeded the use of 
TEG to guide on blood products transfusion (Tapia et al., 2013). TEG was suggested most 
suitable to be used as research purposes until more clinical data been obtained (Hunt et al., 
2015). 
 
Latest recommendation by the European Trauma Guideline is to use the goal-
directed method in assessing the haemostatic resuscitation on major trauma bleeding. 
However there is a need that haemostatic resuscitation to be guided with standard 
laboratory coagulation tests and clinical evidence (Rossaint et al., 2016).  
 
1.4.4  Role of pharmacology in trauma haemostatic resuscitation 
An adjunct to haemostatic resuscitation is the use of pharmacology agent that can 
promote coagulation or inhibit the fibrinolysis. Use of tranexamic acid (TXA) is beneficial 
in cases with likelihood need of massive transfusion ie: patients with significant blood loss 
or at risk of massive bleeding (Schocl et al., 2012). Tranexamic acid is trans-4-
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aminomethylcyclohexane-1-carboxylix acid, a lysin derivate that act as plasmin inhibitor 
that inhibit fibrinolysis (antifibrinolytic). A randomized control trial study of CRASH-2 
showed that early administration (within 3 hours) of tranexamic acid in bleeding major 
trauma cases had higher survival rate with no significant clinical adverse effects. However 
the study data did not supported for fewer transfusion requirement with the use of 
tranexamic acid (Robert et al., 2013). European trauma guideline highly suggested that 
tranexamic acid to be given as soon as possible in cases of haemorrhagic trauma and cases 
with risk of major bleeding (Spahn et al., 2013). Elmer et al., also wrote in their article that 
tranexamic acid should be available in trauma unitas it has time-sensitive effectivenes 
(Elmer et al., 2013). 
As addressed by the European Trauma Management Guideline,  rFVIIa is 
considered only after all measures of damage control resuscitation has been taken, that 
includes blood and blood products transfusion, surgery approach, antifibrinolytic and 
correction of acidosis and hypothermia (Rossaint et al., 2016). This is because rFVIIa can 
only effectively initiates the thrombin burst in optimized coagulation system by direct 
binding to the activated platelet surface with optimal enzymatic activity (Hoffmann M., 
2003).  rFVIIa has poor respond if pH <7.2, platelet count <100 X 109/l and systolic blood 
pressure < 90mmHg (Knudson et al., 2011). A randomized controlled trial, double-blinded 
study on usage of rFVIIa in controlling traumatic haemorrhage showed that rFVIIa 
significantly reduce transfusion in blunt trauma cases that received massive transfusion 
however there was no significant result in penetrating cases (Boffard et. al., 2005). In this 
study, 200 μg/kg rFVIIa given after transfusion 8 unit of RBC and followed with 100 μg/kg 
second and third dose of 1 hour and 3 hour after (Boffard et. al., 2005). However rFVIIa is 
not recommended in isolated traumatic brain injury as it was proven causing poor outcome 
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in traumatic brain injury (TBI) (DeLoughery et al., 2011). rFVIIa adverse effect includes 
increase risk of thromboembolic events (O'Connell et al, 2006). However, risk of 
thromboembolic event was not demonstrated  in bleeding trauma cases that been given 
rFVIIa (Dutton et al., 2011). The recommendation of rFVIIa in bleeding major trauma 
cases is based on risk and benefit clinical judgement (Smith et al., 2014). If need to be use, 
the patient`s relatives need to be informed of it`s out of standard recommended usage with 
possible adverse effects (Spahn et al., 2013).  
 
The use of coagulation factor concentrates may avoid the use of huge volume of 
FFP in treating actively bleed patient in a way to maintain the fibrinogen level 
(Theusingger et al., 2014). Fibrinogen concentrate and prothrombin complex concentrate 
recommended to be used in bleeding trauma algorithm with the benefits of point-of-care 
method ie: TEG and ROTEM, if there is functional fibrinogen deficit or fibrinogen level 
<1.5-2.0 g/l (Rossaint et al., 2016).  
 
Prothrombin complex concentrate has been suggested in bleeding trauma algorithm 
if there is prolonged clot formation finding in ROTEM (Theusingger et al., 2014). 
 
The use of coagulation factors concentrate are effective in treating trauma 
coagulopathy and can reduced the transfusion requirement, which subsquently may 
improve patient`s outcome (Innerhofer et al., 2013). 
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1.4.5    Adverse effects of massive transfusion 
 
 Massive transfusion of allogeneic blood is known to have adverse effects whereby 
large volume of blood has been exposed to patients (Segatchian and Samama, 2012). Such 
adverse effects inlude increase risk of sepsis, cardiac overload and exposure to  vary 
biological response modifier  (Segatchian and Samama, 2012).  
 
 Large volume of plasma associated wih possible risk of ARDS ie: TRALI as 
reported by Inaba (2010) especially in non-coagulapathic trauma patients (Inaba et al., 
2010). The risk is higher if >6 units FFP been transfused. Thus, it is suggested that early 
FFP transfusion is only been considered in patients that the  anticipated need of >10 packed 
cells in 24 hour as part of hemostatisc resuscitation (Elmer et al., 2012). There is report of 
increase risk of mortality and multiorgan failure (MOF) after FFP transfusion in trauma 
(Bochicchio et al., 2008). Contradictry, there was a study that found less MOF and sepsis if 
blood components (other than red cells) were given earlier and was transfused at higher 
ratio (Cotton et al., 2009).  
 
 Infusion of massive volume of packed cells and FFP may cause citrate accumulation 
and resulted in hypocalcemia and hyperkalemia (Elmer et al., 2012). Fluctuation in 
potassium level may occured in massive transfusion cases as stored red packed cells 
contain accumulated potassium (Lier et al., 2008). 
 
 Another adverse effects of massive transfusion is possible transfusion transmitted 
infection such as ie: human immunodefiency virus, hepatits B, dengue etc (Allain et al., 
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2008). Bacterial contamination of stored blood particularly platelet is also a concerning 
risk, and both risks are increasing with increase unit of transfused blood (Elmer et al., 
2012).   
 
1.5 Prediction score of massive transfusion in major trauma 
 
Time to initiate the balanced resuscitation is postulated to be a major determinant in 
improved outcomes of major trauma patients (Callcut et al., 2013). Accurate predictive 
models that can be performed on admission able to identify the patients who will benefit 
from damage control resuscitation, thus optimizing benefit and minimizing risk of 
intractable trauma coagulopathy (Holcomb J. B., 2010). A number of studies that were 
mostly retrospective done in attempt to come out with the predictive factors for anticipating 
the needs of massive transfusion in bleeding major trauma cases.  Several published 
massive transfusion predictive score studies has been summarized by Curry (2012). 
However, the scoring system were not sensitive enough to determine risk of massive 
haemorrhage, thus the score is used only as predictive measures particularly for risk of 
trauma coagulopathy (Curry et al., 2012).  
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Prediction scores for massive transfusion and coagualopathy in trauma (Curry et al., 2012) 
Reference Type of study Aim of prediction 
score 
No. 
patients 
Validated 
Y/N 
Predictors ROC 
Cosgriff et 
al. 
Retrospective 
analysis, 
prospective 
collection of data 
Prediction of 
coagulopathy 
58  
 
N pH 
SBP 
Temperature 
ISS 
 
Ruschholtz 
et al 
Retrospective 
analysis, 
prospective 
collection of data 
Prediction of early 
transfusion  
1103  N free fluid in 
abdomen 
unstable pelvic ring 
# 
age  
SBP 
admission 
from 
scene 
Yücel et al. 
Maegele et 
al. 
Retrospective 
analysis 
Prediction of MT 
(≥10U RBC)  
TASH-Score  
Updated TASH-
Score 
6044 Y using a 
1517 pt set  
Y using a 
5834 pt set 
SBP 
Hb 
Intra-abdominal 
fluid 
Complex long bone 
or pelvic # 
PR 
BE 
Gender 
0.892 
Schreiber et 
al. 
 Retrospective 
analysis Early 
prediction of MT 
(≥10U RBC) 
Early prediction of 
MT (≥10U RBC) 
558  N Hb 
INR 
Penetrating 
mechanism 
0.804 
McLaughlin 
et al. 
Retrospective 
analysi 
Early prediction of 
MT (≥10U RBC s) 
302 N SBP 
pH 
Hct  
PR 
0.839 
Cancio et 
al. 
Retrospective 
analysis  
Prediction of MT 
536 N 
536  N RTS 
PR 
SBP 
DBP 
0.708 
Nunez et al. Retrospective 
review and 
validation 
Validation of 
previous scoring 
systems & predict 
MT with ABC 
score 
596 Y of other 
scores  
N of ABC 
Penetrating 
mechanism 
SBP 
PR 
Positive FAST 
0.859 
Stanworth 
et al. 
Retrospective 
analysis  
Prediction of MT 5693  Penetrating 
mechanism 
SBP 
Time to arrival in 
ED 
Age 
Base Deficit 
PT 
0.81 
ROC : receiver operating curve, SBP: systolic blood pressure, RTA:road traffic accident, PT:prothrombin time, APTT 
:activated thromboplastin time, ULN : upper limit ofnormal, ISS: injury severity score, MT :massive transfusion, RBC : 
red blood cell, PR : pulse rate, BE : base excess, INR : international normalised ratio, RTS :revised trauma score, DBP : 
diastolic blood pressure, FAST :Focussed Assessment with Sonography for Trauma, ED : emergency department. 
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Among widely used massive transfusion predictive score are Trauma Associated 
Scoring for Hemorrhage (TASH), and Assessment of Blood Consumption (ABC). Both are 
derived from civillian subjects with difference in number of variables, in which TASH has 
6 variables, and ABC only listed 4 variables (Brockamp et al., 2012). Details about score as 
described below. 
 
i) Trauma Associated Scoring for Hemorrhage (TASH) Score 
TASH score was developed and validated from 6044 severe blunt trauma 
subjects, and establihed on 2006.. This score had been revalidated internally on 2011 
based 5834 patient`s data base on TraumaRegister DGU®, with specificity of 98%, 
sensitivity of 31% with AUC 0.905, that showed better performance then during 
development period (AUC 0.89) (Maegele et al., 2011). This score comprising of eight 
variables which are given specific score as shown below: 
 
 Variable Value Points 
i. Gender male 1 
ii. Pelvic fracture (AIS 5 ≥ 5) clinically unstable 6 
 Femur fracture (AIS 5 ≥ 3) open and/or dislocated 3 
iii. Free IF (FAST) (AIS 4 ≥ 3) present 3 
iv. Heart rate (bpm) > 120 2 
v. Systolic blood presure (mmHg) < 100 4 
  < 120 1 
  < 7 8 
  < 9 6 
vi. Hemoglobin (g/dl) < 10 4 
  < 11 3 
  < 12 2 
  < -10 4 
vii. Base excess (mmol/L) < -6 3 
  < -2 1 
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The complexity of this score is that it need to be calculated with formula as shown that 
make it less ease to use (Calcutt et al., 2013) . Below is TASH calculation formula :  
p = 1/[(1 + exp (5.4 − 0.3*TASH)] 
Cases with score > 16, gives 50% prediction for MT and if score is > 27, the risk for MT is 
100% (Yücel et al., 2006). This score was applied by European Trauma Guideline in their 
massive hemorrhage protocol (Rossaint et al., 2016). 
 
ii) Assessment of blood consumption (ABC) score  
This score consist of four non-weighted variables at patient`s arrival at ED 
which are: 
- Penetrating injury 
- SBP <  90mmHg 
- HR > 120mmHg and 
- Positive FAST scan 
All variables are non-laboratory and non-weighted parameters. This simple and easy to use 
score been developed using data of 596 level I civillian trauma patients. ABC score of > 2 
had 75% sensitive and 86% specific for predicting the need of massive transfusion (Nunez 
et al., 2009). Analysis study by Nunez (2009) in attempt to compare the ABC score with 
TASH score, showed that ABC score had equal prediction level and the difference between 
the score was not statiscally significant. By practical, this score is simpler and had 
comparable accuracy of predicting MT (Nunez, 2009). This score been applied in MTP by 
number of trauma centre wordwide, ie Singapore and  US (Calcutt et al., 2013; Chay et al., 
2015).  
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Massive hemorhage guideline or protocol in trauma is suggested to be implemented 
based on local evidence-based condition (Rossaint et al., 2016). Among recent study in  
developing the predictive score is Prince Wales Hospital (PWH) score, that developed in 
Hong Kong. This score derived from retrospective analysis of 1,891 civilian trauma patient 
in single level 1 trauma centre. The score included 8 variables with different points as 
shown below :  
 Variable Value Points 
i. Displaced pelvic fracture   1 
ii. FAST/Abd CT-positive                   2 
iii. HR  ≥ 120 1 
iv.         SBP  < 90 3 
v. Hemoglobin (g/dl) ≤ 7 10 
  7.1 to 10 1 
vi. Base deficit  > 5 1 
vii.  GCS < 8 1 
At score of  ≥6, the correct classification in predicting MT requirement was was 96.9%, 
sensitivity of 31.5% , specificity of 99.7%, with incidence of MT of 82.9%. 
 
 Brockamp (2009) had done validation and comparison study between ABC, TASH 
and PWH score using 5,147 patients was extracted from the TraumaRegister DGU® of the 
German Trauma Society, with 95% of the cases were blunt trauma. TASH score had 
highest overall accuracy (AUC 0.889), followed by PWH score (AUC 0.860) and ABC 
score had AUC of 0.760. The sensitivity and specificity for all the scores is shown below.  
Score  TASH PWH ABC 
AUC 0.889 0.860 0.763 
Sensititive 84.4% 80.6% 76.1% 
Specific 78.4% 77.7% 70.3% 
 
 21 
 
The author concluded that weighted and more sophisticated systems such as TASH and 
PWH scores including higher numbersof variables perform superior over simple non-
weighted models (Brockamp et al., 2009).  
 
 
1.6  Injury severity score  
 
Baker (1974) described injury severity score in their article. The Injury Severity 
Score (ISS) is an anatomical scoring system that provides an overall score for patients with 
multiple injuries. Each injury is assigned with an Abbreviated Injury Scale (AIS) score (1 
to 6) and is allocated to one of six body regions which are (Head, Face, Chest, Abdomen, 
Extremities (including pelvis), andExternal) and categorized as minor (1), moderate (2), 
serious (3), severe (4), critical (5) and unsurvivable (6) . Only the highest AIS score in each 
body region is used. The ISS score takes values from 0 to 75. If an injury is assigned an 
AIS of 6 (unsurvivable injury), the ISS score is directly assigned to 75. The 3 most severely 
injured body regions have their score squared and added together to produce the ISS score 
(Baker et. al., 1974). The score generally represents linear correlation with  mortality, 
morbidity, hospital stay and other measures of severity. The disadvantage of ISS scoring 
when there is error in initial AIS scoring. Moreover, real injuries may only known after 
completion of full investigation or after surgery.  Thus,  the ISS is not useful as a triage tool 
(Trauma.Org, 2006). AIS is summarized as below :  
Score Severity 
1 Minor 
2 Moderate 
3 Serious 
4 Critical 
5 Critical 
6 Unsurvivable 
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1.7  Research Justification And Benefit 
 
National Blood Service guideline in trauma and massive transfusion is based on 
both laboratory and clinical judgement with estimation of blood loss, further expectation of 
blood loss, and clinical signs and symptoms (National Blood Centre Ministry of Health 
Malaysia, 2008a). Laboratory results may not be immediately available and coagulopathy 
states can change rapidly. Massive transfusion is related higher mortality rate and longer 
length of hospital stay, moreover unguided massive transfusion is tend to cause 
injudiciously usage of blood (Rainer et al., 2011; Livingston et al., 2014; Mitra et al., 
2014). Thus, guidance is needed for blood and blood products administration to optimize 
patient outcome and improved of blood product management (Malone et al., 2006). Study 
by Livingston (2014) showed that massive transfusion without protocol does associated 
with longer hospital stay and increased mortality (Livingston et al., 2014). Protocols are 
needed to ensure that resuscitation occurs in a coordinated fashion and that patients are 
given appropriate amounts of blood and blood products (Livingston et al., 2014). 
This retrospective study is conducted in Emergency and Trauma Department of 
Hospital Kuala Lumpur (EDHKL). The purpose of this study is to determine the prevalence 
and associated factors of massive transfusion among major trauma in adult patient.   The 
associated factors that are taken into account are based on previous studies on predictive 
factors for likelihood of initiating the massive transfusion, as well as taken account of 
availability and practice in Emergency and Trauma Department of Hospital Kuala Lumpur 
(EDHKL). The factors that will be analysed in this study are heart rate ≥120/min, systolic 
